Sunday, October 21, 2018
- 9:00AM-11:00AM
-
Abstract Number: 806
Estradiol Levels Are Elevated in Older Men with Diffuse Cutaneous SSc and Are Associated with Decreased Survival
Systemic Sclerosis and Related Disorders – Clinical Poster I- 9:00AM-11:00AM
-
Abstract Number: 102
Estrogen Controls the Expression of Serine Arginine-Rich Splicing Factor 1 (SRSF1) in Human T Lymphocytes Via Transcriptional and Post-Transcriptional Mechanisms
Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster I- 9:00AM-11:00AM
-
Abstract Number: 272
Ethnic Disparities in Lupus Nephritis Outcomes in the Inland Empire: Findings from the Southern California Lupus Registry
Healthcare Disparities in Rheumatology Poster- 9:00AM-11:00AM
-
Abstract Number: 185
Evaluating Medical Student Confidence and Performance of the Pediatric Musculoskeletal Exam
Education Poster- 9:00AM-11:00AM
-
Abstract Number: 199
Evaluating the Perception Among Rheumatologists of Maintenance of Board Certification Programs in the United States
Education Poster- 9:00AM-11:00AM
-
Abstract Number: 570
Evaluation of CXCL13, sICAM1, MMP-3 and S100A8/A9 As Serum Biomarkers in Patients with Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab
Rheumatoid Arthritis – Treatments Poster I: Strategy and Epidemiology- 9:00AM-11:00AM
-
Abstract Number: 792
Evaluation of Esophageal Dysmotility in Systemic Sclerosis: Clinical VALUE of Computed Tomography
Systemic Sclerosis and Related Disorders – Clinical Poster I- 9:00AM-11:00AM
-
Abstract Number: 591
Evaluation of MRI Ramris Score and Clinical Response in Patients with ACPA Positive Undifferentiated Arthritis Treated with Infliximab Versus Placebo
Rheumatoid Arthritis – Treatments Poster I: Strategy and Epidemiology- 9:00AM-11:00AM
-
Abstract Number: 189
Evaluation of Rheumatology Lectures By Clinical Students in a Nigerian Medical School: Learning from the Learners
Education Poster- 9:00AM-11:00AM
-
Abstract Number: 478
Evidence Based Recommendations for Corticosteroid Tapering/Discontinuation in New Onset Juvenile Dermatomyositis Patients: Results from the Paediatric Rheumatology International Trials Organisation
Pediatric Rheumatology – Clinical Poster I: Lupus, Sjögren’s Disease, and Myositis- 9:00AM-11:00AM
-
Abstract Number: 112
Evidence for Altered Peroxisome Proliferator Activated Receptor (PPAR) Pathway Activity in a Transgenic Mouse Model of Scleroderma (TβRIIΔk-fib): Analysis of Mouse Skin, Lung and Explanted Cells
Systemic Sclerosis and Related Disorders – Basic Science Poster I- 9:00AM-11:00AM
-
Abstract Number: 211
Excess in Prevalence of Functional Disability in Patients with Rheumatoid Arthritis: Does Serologic Status Matter?
Epidemiology and Public Health Poster I: Rheumatoid Arthritis- 9:00AM-11:00AM
-
Abstract Number: 213
Excessive Risk of Major Cardiovascular Events in Sero-Positive Rheumatoid Arthritis and in Patients with Active Disease
Epidemiology and Public Health Poster I: Rheumatoid Arthritis- 9:00AM-11:00AM
-
Abstract Number: 577
Expanded Autoantibody Profiles Predict Treatment Response to Biologic Therapy in Rheumatoid Arthritis